In this study, to assess the performance of the AdvanSure Mycobacteria GenoBlot assay (AdvanSure assay), we compared its performance with that of the GenoType Mycobacterium CM/AS assay (GenoType assay) for the identification of non-tuberculous mycobacteria (NTM). Twenty-four reference strains and 103 consecutive clinical NTM isolates were analysed. The accuracy rates for the 24 reference strains were 87.5 and 95.8 % for the AdvanSure and GenoType assays, respectively. For the 103 clinical isolates, a 91.3 % (94/103) concordance rate was observed between the two assays. The majority (7/9) of discrepancies were isolates identified as Mycobacterium avium complex (MAC) by only the AdvanSure assay. All of these isolates except one were confirmed as MAC by sequence-based typing. The AdvanSure assay showed comparable performance to the GenoType assay and can be useful as a routine method for NTM identification in the clinical setting, especially where MAC is the main cause of NTM infection.
INTRODUCTION
Non-tuberculous mycobacteria (NTM) are increasingly recognized pathogens of pulmonary infection and extrapulmonary infection such as lymphadenitis, skin and soft tissue infections and disseminated disease (van Ingen et al., 2009) . The prevalence of NTM is progressively increasing worldwide and is reported as an annual prevalence of 20 to 40 cases/100 000 individuals in the USA (Adjemian et al., 2012; Prevots & Marras, 2015) . Over 150 species of NTM have been identified, of which approximately 25 are pathogenic (van Ingen, 2013) . Since patterns of antibiotic susceptibility vary among different NTM species, accurate and rapid identification of NTM species is important (Griffith et al., 2007; Griffith, 2010) . Conventional biochemical tests for mycobacterial identification have mostly been replaced by molecular methods such as DNA sequencing, line probe assay (LPA), PCR restriction fragment length polymorphism analysis and/or real-time PCR, which have the general advantages of being more rapid and more accurate Ramis et al., 2015) . Nonetheless, DNA sequencing remains costly and time consuming, and PCR restriction fragment length polymorphism analysis is limited to the use of restriction enzymes and is labour intensive as the number of tests increases. Although matrix-assisted laser desorption/ionization time-of-flight MS is emerging as a promising tool, further improvements are still needed (Kodana et al., 2016; Marekovic et al., 2016; RodriguezSanchez et al., 2016) . LPAs are widely used as identification methods, since they have been proven to be sensitive, specific, rapid and cost-effective. There are numerous studies reporting the performance of commercial LPA kits, including the GenoType assay and the INNO-LiPA (Fujirebio) assay (Tortoli, 2003; Padilla et al., 2004; Sarkola et al., 2004; Makinen et al., 2006; Russo et al., 2006; Lee et al., 2009 ).
The AdvanSure Mycobacteria GenoBlot assay (AdvanSure assay; LG Life Sciences) was developed for the identification of NTM species and is approved by the Korean Ministry of Food and Drug Safety. It is a LPA that uses a one-tube nested multiplex PCR and a reverse hybridization technique to detect 23 NTM species. The target for this LPA is the internal transcribed spacer region located between 16S rDNA and 23S rDNA (LG Life Sciences, 2013; Kim et al., 2015) . In the present study, we compared the performance of the AdvanSure assay with that of the GenoType Mycobacterium CM/AS assay (GenoType assay; Hain Lifescience), which has been proved to be sensitive and specific for NTM identification (Franco-Alvarez de Luna et al., 2006; Gitti et al., 2006; Russo et al., 2006) . The GenoType assay targets the 23S rRNA gene and is one of the most widely utilized LPAs (Richter et al., 2006; Hofmann-Thiel et al., 2011) .
METHODS
Isolates. This study was carried out at a tertiary care hospital in Seoul, South Korea, and was approved by the Institutional Review Board of Samsung Medical Center. A total of 24 reference strains (18 mycobacterial and 6 other strains including Gordonia sp., 2 Nocardia spp., 2 Rhodococcus spp. and Tsukamurella sp.) and 103 NTM isolates from consecutive clinical specimens obtained from August to December 2014 were used for this study. The names of reference strains are given in Table 1 . Clinical specimens were processed with 2 % N-acetyl-L-cysteine-sodium hydroxide followed by centrifugation at 3000 g for 20 min (Della-Latta, 2010) . Decontaminated samples were inoculated in a mycobacterial growth indicator tube (MGIT 960 system; Becton Dickinson) and incubated for 6 weeks (Somoskovi et al., 2000) and also inoculated on 3 % Ogawa agar (Shinyang) and incubated for 6 weeks (Pfyffer, 2015) .
AdvanSure Mycobacteria GenoBlot assay. A loopful of bacteria from cultures on solid medium was mixed with 200 µl distilled water and centrifuged at 20 000 g for 3 min. Cultures grown in liquid MGIT culture medium (1 ml) were centrifuged at 20 000 g for 3 min. The precipitates were resuspended in 50 µl DNA extraction buffer (LG Life Sciences) and heated to 95 C to 100 C for 20 min. After centrifugation, the supernatants were used for PCR (LG Life Sciences, 2013) .
A total of 7.5 µl of extracted DNA was used for PCR. The PCR included one cycle of 2 min at 50 C, a uracil-DNA glycosylase pretreatment step to prevent carry-over contamination and 10 min at 95 C. A one-tube nested PCR method was used, which consisted of two amplification steps performed without reopening the tube between the first step and the second step (Giannini et al., 1999) . The first round of amplification involved 15 cycles of 30 s at 94 C, 1 min at 65 C and 30 s at 72 C. The second round of amplification consisted of 38 cycles of 30 s at 94 C, 1 min at 55 C and 30 s at 72 C and was followed by a final extension at 72 C for 10 min. Hybridization was performed in a hybridizer oven (JHO-10LG; Jeio Tech) for 30 min followed by washing, enzyme conjugation reaction and colour development according to the manufacturer's instructions. The results were interpreted using the AdvanSure GenoLine Scan program. Detectable NTM species are listed in Table S1 (available in the online Supplementary Material).
GenoType Mycobacterium CM/AS assay. A loopful of bacteria from cultures on solid medium was suspended in 300 µl distilled water.
Cultures grown in 1 ml liquid MGIT culture medium were centrifuged at 10 000 g for 15 min. The precipitates were resuspended in 100 to 300 µl distilled water and heated to 95 C for 20 min. After centrifugation, the supernatants were used for PCR (Hain Lifescience, 2011) .
A total of 5 µl of the treated supernatant was used for PCR. One-tube nested PCR amplification was carried out with the following conditions: one cycle at 95 C for 15 min, followed by the first round of amplification consisting of 10 cycles of 30 s at 95 C and 120 s at 58 C. The second round of amplification involved 20 cycles of 25 s at 95 C, 40 s at 53 C and 40 s at 70 C, with a final extension at 70 C for 8 min. Reverse hybridization and detection were carried out on a shaking water bath (TwinCubator; Hain) according to the manufacturer's instructions (Singh et al., 2013) . The developed strips were attached to the evaluation sheet and interpreted with the help of the provided interpretation chart. Separate observers interpreted the results independently in a blind fashion. Detectable NTM species are listed in Table S1 .
Resolution of discrepancy. Clinical samples with discrepant results between the two assays were confirmed by multigene sequence-based typing. The 16S rRNA, rpoB and hsp65 genes were sequenced according to the protocol outlined in the Clinical and Laboratory Standards Institute guideline MM18-A (CLSI, 2008). The primers used for sequencing are listed in Table S2 . (Telenti et al., 1993; De Beenhouwer et al., 1995; Kim et al., 1999; Jang et al., 2014) . The amplified sequences were analysed with the GenBank database using BLAST analyses provided by the National Center for Biotechnology Information.
RESULTS
Analytic specificity test results for the two assays using reference strains are summarized in Table 1 . The accuracy rates for the 24 reference strains were 87.5 % (21/24) and 95.8 % (23/24) for the AdvanSure and GenoType assays, respectively. The invalid percentage for the AdvanSure assay was 12.5 % (3/24): Mycobacterium alvei and Mycobacterium brisbanense were misidentified as Mycobacterium vaccae and Mycobacterium flavescens, respectively, and Mycobacterium phlei was misidentified as a non-mycobacterial species. The invalid percentage of the GenoType assay was 4.2 % (1/24): Mycobacterium obuense was misidentified as a non-mycobacterial species. Cross-reactivity for non-mycobacterial Corynebacterineae spp., such as Rhodococcus, Gordonia, Nocardia or Tsukamurella spp., was not observed with either assay.
Among the 103 clinical isolates, a 91.3 % (94/103) concordance rate was observed between the two assays ( Table 2) . The most commonly identified organism using the two assays was Mycobacterium avium, followed by Mycobacterium intracellulare and the Mycobacterium abscessus complex. Discrepancy in results between the two kits was observed in nine isolates (8.7 %), which were subsequently sequenced for discrepancy resolution. The sequences were aligned with existing databank sequences in the National Center for Biotechnology Information using bioinformatics tools (Table 3 ). The phylogenetic trees of the three genes using the reference strains are presented in Figs S1 to S3. The majority (7/9) of discrepancies involved isolates identified as M. avium complex (MAC) by only the AdvanSure assay. All of these isolates except one (isolate 3) were confirmed as MAC by multigene sequencing. One of the M. intracellulare isolates (isolate 2) detected by the AdvanSure assay was ultimately confirmed as Mycobacterium chimaera, a recently described new species different from M. intracellulare. The isolate confirmed as Mycobacterium mucogenicum (isolate 8) was correctly identified only by the GenoType assay. Three samples were identified as coinfection with two NTMs in the AdvanSure assay, while a single NTM species was detected by the GenoType assay: the sequencing result for isolate 3 was in agreement with the GenoType assay; however, the remaining two isolates (isolates 7 and 9) gave inconclusive sequencing results because a mixed pattern was observed in the chromatogram. In total, excluding two isolates with inconclusive sequencing results, out of seven isolates, four and two were correctly identified at the species level by the AdvanSure assay and the GenoType assay, respectively. The clinical sensitivity, specificity, positive predictive value and negative predictive value of the AdvanSure and GenoType assays are presented by NTM species in Table 4 . The sensitivity and specificity of the AdvanSure assay by each species were 100 and 98.5 %, respectively. For the GenoType assay, the sensitivity ranged from 93.7 to 100 %, and the specificity was 100 %.
DISCUSSION
In this study, we demonstrate that the recently introduced commercial AdvanSure assay shows comparable performance to the commonly used GenoType assay. In analytical specificity using reference strains, the AdvanSure and GenoType assays correctly identified 21 and 23 out of 24 reference strains, respectively. The AdvanSure assay misidentified three reference strains (M. alvei, M. brisbanense and M. phlei) for which specific probes were not available on the test strip. M. alvei gave positive results for both M. fortuitum complex and M. vaccae probes. Positive reaction to the M. fortuitum complex probe is a concordant result because M. alvei belongs to the M. fortuitum complex (Garcia-Agudo et al., 2011). However, positive reactions of M. alvei and M. brisbanense to the probes for M. vaccae and M. flavescens, respectively, are cross-reactivity caused by limited probe specificity for M. vaccae and M. flavescens in the AdvanSure assay. Moreover, M. phlei did not react with any probe of the AdvanSure assay. The most likely explanation for this negative result is unsuccessful DNA amplification with the AdvanSure primers (Sarkola et al., 2004) . In contrast, the GenoType assay did not show cross-reactivity against other specific probes, although M. obuense was misidentified as a non-mycobacterial species because the conjugation and universal controls were positive, but the genus control was not stained. Although all the reference strains that were incorrectly identified (M. alvei, M. brisbanense, M. phlei and M. obuense) are not frequently encountered NTM species and are rarely or never associated with human infection, these misidentifications should be taken into account (Griffith et al., 2007; Weiss & Glassroth, 2012) .
In tests with 103 consecutive clinical NTM isolates, a total of nine discordant results were obtained. The majority (7/ 9) of these were misidentification of MAC, the most frequently encountered species in clinical specimens. It is of note that six MAC isolates (isolates 1, 2 and 4-7 in Table 3) were misidentified by the GenoType assay as negative or non-mycobacterial species. Despite the presence of speciesspecific probes on the strip, both the genus control and species-specific probe reaction were negative. Identification failure for MAC by the GenoType assay was also seen in previous studies (Padilla et al., 2004; Sarkola et al., 2004; Makinen et al., 2006; Richter et al., 2006) . The false-negative results (negative reactions for both the universal and genus controls) by the GenoType assay might be due to unsuccessful DNA amplification with the GenoType primers (Sarkola et al., 2004) . Also, the incorrectly assigned non-mycobacteria species results suggest weak hybridization with the species-specific probe, which might be caused by heterogeneity in the probe-binding region of the 23S rDNA target (Sarkola et al., 2004) . Variation may depend on the geographical region and origin of the isolates (Legrand et al., 2000; Bartfai et al., 2001; Sarkola et al., 2004 ), although we were not able to demonstrate whether the variations depended on the geographical region based on the phylogenetic analysis from multigene (16S rRNA, rpoB and hsp65 genes) sequences (Figs S1-S3). Since MAC is not only the most prevalent NTM found in many geographic regions but also a common cause of pulmonary NTM disease, misidentification of MAC can influence treatment decisions and disease outcome (Simons et al., 2011; Prevots & Marras, 2015) . In contrast to the GenoType assay, MAC was correctly identified from clinical isolates by the AdvanSure assay. Although cross-reaction of M. intracellulare to M. chimaera was observed, this can be explained by their genetic relatedness (Park et al., 2010) . M. chimaera is a recently described new MAC species that is distinct from M. intracellulare. Previous studies reported that molecular genetic tools used in clinical laboratories do not differentiate M. chimaera from M. intracellulare (Schweickert et al., 2008; Park et al., 2010) . Evaluation of the AdvanSure assay for NTM Inconclusive § *The conjugation control was positive, but both the universal and genus controls were negative. †The conjugation and universal controls were positive, but both the genus control and the species-specific probe reaction were negative. ‡PCR failure, unsatisfactory sequence quality or mixed pattern in the chromatogram. §Mixed isolate cannot be excluded.
One of the limitations of the AdvanSure assay is that a small number of infrequently encountered strains are cross-reactive to other species-specific probes. In addition, the AdvanSure assay has limited resolution of patterns that represent more than one species such as M. abscessus complex or M. lentiflavum/M. genavense. This is an intrinsic limitation of the LPA method, and other techniques are necessary for further discrimination.
In conclusion, the AdvanSure assay shows comparable performance to the GenoType assay and will therefore be useful as a routine method to identify NTM species in a clinical setting, especially where MAC is the main cause of NTM infection. PPV, positive predictive value; NPV, negative predictive value; CI, confidence interval.
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